Advances in D-dimer testing: progress in harmonization of clinical assays and innovative detection methods

Rong Zhao,Mengran Li,Peng Xiao,Dewei Song,Hongmei Li

DOI: https://doi.org/10.1007/s00216-024-05207-x

2024-03-20

Analytical and Bioanalytical Chemistry

Abstract:The D-dimer is a sensitive indicator of coagulation and fibrinolysis activation, especially valuable as a biomarker of intravascular thrombosis. Measurement of plasma D-dimer levels plays a crucial role in the diagnosis and monitoring of conditions such as deep vein thrombosis, pulmonary embolism, and disseminated intravascular coagulation. A variety of immunoassays, including enzyme-linked immunosorbent assays, latex-enhanced immunoturbidimetric assays, whole-blood aggregation analysis, and immunochromatography assays, are widely used in clinical settings to determine D-dimer levels. However, the results obtained from different D-dimer assays vary significantly. These assays exhibit intra-method coefficients of variation ranging from 6.4% to 17.7%, and the measurement discrepancies among different assays can be as high as 20-fold. The accuracy and reliability of D-dimer testing cannot be guaranteed due to the lack of an internationally endorsed reference measurement system (including reference materials and reference measurement procedures), which may lead to misdiagnosis and underdiagnosis, limiting its full clinical application. In this review, we present an in-depth analysis of clinical D-dimer testing, summarizing the existing challenges, the current state of metrology, and progress towards harmonization. We also review the latest advancements in D-dimer detection techniques, which include mass spectrometry and electrochemical and optical immunoassays. By comparing the basic principles, the definition of the measurand, and analytical performance of these methods, we provide an outlook on the potential improvements in D-dimer clinical testing.

chemistry, analytical,biochemical research methods

What problem does this paper attempt to address?

The paper primarily discusses the issues present in the detection methods of D-dimer and proposes improvement measures. D-dimer is a sensitive indicator of coagulation and fibrinolysis activation, and it holds significant value in diagnosing intravascular thrombosis. However, the various immunoassays currently used in clinical practice (such as enzyme-linked immunosorbent assay, latex-enhanced immunoturbidimetric assay, etc.) show significant differences in measuring D-dimer levels, leading to inconsistent results that may cause misdiagnosis or missed diagnosis.

The paper points out several key issues:
1. **Incomparability of results**: The differences in results between different D-dimer detection methods can be up to 20 times, and the coefficient of variation (CV) ranges from 6.4% to 17.7%.
2. **Lack of standardized reference system**: The absence of an internationally recognized reference measurement system, including reference materials and reference measurement procedures, affects the accuracy and reliability of detection results.
3. **Antibody specificity issues**: Different antibodies have different preferences for fibrin degradation products of different molecular weights, leading to result discrepancies.
4. **Non-uniform calibration standards**: Different manufacturers use different calibration substances, resulting in arbitrary numerical results.

To address these issues, the paper proposes some advancements:
1. **New detection technologies**: For example, mass spectrometry (LC-MS/MS) and electrochemical and optical immunoassays, which improve sensitivity, specificity, and accuracy.
2. **Standardization efforts**: By establishing internationally recognized reference materials and measurement procedures to improve result consistency, although this process remains challenging.

In summary, the paper aims to enhance the accuracy and reliability of D-dimer clinical detection by thoroughly analyzing existing challenges, the latest advancements, and potential improvement measures.